Through a tissue engineering approach, the stem cells from human exfoliated deciduous teeth (SHED), which have differentiation ability similar to that of bone marrow-derived mesenchymal stem cells (MSCs), are seeded in clinical-grade scaffolds.
- ✔ Category
- ✔ Disease& Specialty
- ✔ R&D Stage
- ✔ Collaboration Option
- ✔ Target Market
➤ Innovative Medical Device
➤ Inflammatory Disease
➤ Orthopedics / Musculoskeletal
➤ New Drug
Request for Collaboration
- Advantages include replacing complicated surgical procedures, such as harvesting cells from cartilage allografting, or bone marrow .
- Promoting the repair and functional regeneration of cartilage affected by degenerative OA, and improving patients' quality of life.
- Low immune risk
The treatment candidates include patients with acute cartilage injury or minor and moderate OA.